This cohort study of adults with advanced cancer compares the use of targeted therapy during first-line therapy for patients with no biomarker testing, comprehensive genomic profiling testing, and non–comprehensive genomic profiling testing.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2836387